You are viewing: Middle East Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Middle East Long Read Sequencing Market was valued at $21.7 Million in 2024 and projected to reach to $73.3 Million by 2029, representing a compound annual growth rate of 27.6%. The Middle East long read sequencing market is poised for substantial growth through 2029, driven by increasing healthcare expenditure, government support for precision medicine programs, and rising prevalence of genetic disorders requiring advanced diagnostic capabilities.

Middle East Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Middle East Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 27.6%, reflecting the region's increasing adoption of advanced genomic technologies in clinical diagnostics and research applications.
  • The Middle East's healthcare infrastructure modernization and rising investment in precision medicine are driving demand for long read sequencing platforms that offer superior accuracy and longer read lengths compared to traditional short-read technologies. In the Middle East, key growth catalysts include expanding genomic research initiatives, growing prevalence of genetic disorders, and enhanced healthcare spending across Gulf Cooperation Council (GCC) nations.
  • The Middle East is witnessing increased collaboration between academic institutions and healthcare providers to establish genomic sequencing capabilities.
  • By 2029, the Middle East market is expected to capture significant value as hospitals and diagnostic centers in the region integrate long read sequencing into routine clinical workflows, supported by regulatory frameworks and government-backed genomic initiatives..

Key Market Statistics

  • CAGR (2024-2029) 27.6% CAGR
  • Market Size, 2024 ~USD 21.7 Million
  • Forecast, 2029 ~USD 73.3 Million
  • Geography Middle East

Middle East Long Read Sequencing Market Overview

Rapid Market Expansion :

The Middle East long read sequencing market is growing at 27.6% CAGR, significantly outpacing global adoption rates and demonstrating strong regional commitment to genomic innovation and precision medicine initiatives.

Healthcare Infrastructure Investment :

Major Gulf states are investing heavily in modernizing healthcare infrastructure and establishing genomic research centers, creating favorable conditions for long read sequencing technology adoption across clinical and research settings.

Clinical Diagnostics Focus :

The region is increasingly leveraging long read sequencing for rare disease diagnosis and cancer genomics, with healthcare providers recognizing the technology's superior accuracy in detecting complex genetic variations.

Strategic Regional Growth :

Saudi Arabia and UAE are leading market drivers with combined market size of $41.5 million, positioning the Middle East as an emerging hub for advanced genomic technologies in the broader MENA region.

Middle East Long Read Sequencing Market Dynamics

  • Key regional players are establishing partnerships with international genomics firms to enhance local expertise and service delivery. Expanding clinical applications in oncology, infectious disease diagnostics, and rare genetic disorder identification will accelerate market penetration.
  • The region's young, growing population and improving healthcare accessibility create significant opportunities for long read sequencing adoption, while regulatory frameworks continue to evolve to support genomic medicine integration into standard clinical practice..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The Middle East long read sequencing market is valued at $21.7 million in 2024 and will grow to $73.3 million by 2029, representing a 27.6% CAGR.
    • The Middle East is investing heavily in precision medicine infrastructure, driving adoption of advanced sequencing technologies across healthcare systems.
    • The Middle East's genomic research initiatives and government support are accelerating clinical integration of long read sequencing platforms.
    • The Middle East market growth is fueled by rising genetic disorder prevalence and increased healthcare spending in GCC nations.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Middle East Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Genomics Technology Providers : Long read sequencing platform manufacturers and reagent suppliers need Middle East market data to assess regional demand, identify distribution partners, and develop localized go-to-market strategies.
    • Healthcare Institutions & Hospitals : Regional hospitals and diagnostic centers require market intelligence to benchmark their genomic capabilities, justify capital investments in sequencing infrastructure, and plan service expansion.
    • Investment & Private Equity Firms : Investors targeting the Middle East healthcare sector need comprehensive market sizing and growth projections to evaluate investment opportunities in genomics companies and healthcare technology ventures.
    • Research & Academic Institutions : Universities and research centers in the Middle East use market data to secure funding, establish genomics programs, and collaborate with industry partners on precision medicine initiatives.
    • Healthcare Policy & Government Bodies : Regional health ministries and regulatory agencies require market insights to inform precision medicine policies, healthcare technology adoption roadmaps, and genomic medicine integration strategies.

    Middle East vs. other regions

    HowMiddle East compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 779 Million · 33.1% wtd CAGR ·
    Europe
    ~USD 526.3 Million · 33.7% wtd CAGR ·
    Asia Pacific
    ~USD 450.4 Million · 34.9% wtd CAGR ·
    Latin America
    ~USD 86.8 Million · 29.9% wtd CAGR ·

    Countries within Middle East - compare and drill down

    Country2025 size (native)
    Saudi ArabiaUSD 21 Million
    UAEUSD 20.5 Million
    GCC CountriesUSD 46.6 Million
    Rest Of Middle EastUSD 26.7 Million

    Country market size visualization

    Saudi Arabia
    USD 21 Million
    UAE
    USD 20.5 Million
    GCC Countries
    USD 46.6 Million
    Rest Of Middle East
    USD 26.7 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for the Middle East ($21.7M in 2024) with detailed 5-year forecasts to 2029, enabling accurate business planning and investment decisions specific to this high-growth region.
    • Country-Level Insights : Access granular data on Saudi Arabia, UAE, and GCC markets to identify the most promising sub-regional opportunities and tailor market entry strategies accordingly.
    • Competitive Landscape Analysis : Understand regional competitive dynamics, key players, and market consolidation trends unique to the Middle East long read sequencing sector to inform strategic positioning.
    • Growth Driver Identification : Discover region-specific factors accelerating adoption—including healthcare infrastructure investments, government precision medicine initiatives, and clinical application expansion in the Middle East.
    • Investment & Partnership Opportunities : Identify high-potential partnerships, acquisition targets, and investment opportunities within the Middle East's rapidly expanding genomic technology ecosystem.

    Frequently asked questions

    What is the current market size of long read sequencing in the Middle East?

    The Middle East long read sequencing market was valued at $21.7 million in 2024 and is expected to reach $73.3 million by 2029.

    What is the projected growth rate for long read sequencing in the Middle East?

    The Middle East long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 27.6% from 2024 to 2029.

    What are the main drivers of long read sequencing adoption in the Middle East?

    Key drivers in the Middle East include healthcare infrastructure modernization, increased precision medicine investments, government-backed genomic initiatives, and rising prevalence of genetic disorders.

    Which countries in the Middle East are leading long read sequencing adoption?

    Gulf Cooperation Council (GCC) nations, including the United Arab Emirates and Saudi Arabia, are leading the adoption of long read sequencing technologies in the Middle East.

    How is the Middle East healthcare sector integrating long read sequencing?

    The Middle East is integrating long read sequencing through collaborations between academic institutions and healthcare providers, establishment of genomic centers, and incorporation into routine clinical diagnostic workflows.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status